What we’re doing

Current influence and advocacy work

Access to Treatment

Men with prostate cancer need equal access to the effective treatments, regardless of what province they live in. That’s not always the case today. We will change that with the help of men, families and clinicians who provide their personal and professional experience to enhance drug review processes.
Key areas:
  • Ensure all provincial health plans fund life-saving drugs and treatments
  • Ensure men in every province have the same access to these drugs

Here’s how we make a difference - together:

Fighting for access to drugs

After consultations, Health Canada approved ERLEADA (Apalutamide) an oral treatment for men with non-metastatic castration-resistant prostate cancer. This was a crucial step in offering men with this type of advanced cancer a treatment option for the first time, and in changing their outcomes.
How did Prostate Cancer Canada help?

We made sure patient and clinician voices, experiences and opinions were heard throughout the decision-making process

Lobbying for PSA test funding in British Columbia and Ontario

The PSA test cost is covered by the government for asymptomatic men everywhere in Canada except British Columbia and Ontario when ordered by a doctor. This needs to change. All men need access to this vital test, which is the first step to early diagnosis. The out-of-pocket cost is a barrier for many families. This means the men may not be accessing potentially life-saving information about their health.
When prostate cancer is caught early, survival is close to 100%. We call on the governments of British Columbia and Ontario to remove this barrier to early diagnosis. We are continuing to work with these provinces to ensure fair and equal coverage for this important test.

Supporting the cause is as easy as a few clicks. If you live in Ontario, take 30 seconds and send an email to your local member of provincial parliament (MPP) explaining that no one should lose a father, brother, husband, or friend over an affordable blood test.
Do you live in British Columbia or Ontario and want to get involved in advocating for PSA test coverage? Email advocacy@prostatecancer.ca to learn how.

Take action


Learn more about upcoming opportunities to lend your voice and take action.

Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Click here for news archive